Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is 12.19% vs 3.91% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is -17.21% vs -5.73% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is -16.69% vs -4.42% in Mar 2025
Interest
YoY Growth in quarter ended Mar 2026 is -100.00% vs 0.00% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025
Compare Quarterly Results Of Jiangsu Jibeier Pharmaceutical Co. Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is -13.46% vs 4.85% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 12.19% vs 3.91% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is -37.17% vs 39.40% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -17.21% vs -5.73% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is -35.05% vs 35.43% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -16.69% vs -4.42% in Mar 2025
Quarterly - Interest
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025
YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025






